Nymbl Science

Nymbl Science is a leading provider of a scientifically proven fall prevention program tailored for Medicare Advantage members. The company's unique digital mobility platform has demonstrated tangible outcomes, positioning it as a transformative solution for health plans and their members. At Nymbl, the focus lies on delivering tangible results, including a guaranteed $3 PMPM cost savings and a 3:1 ROI by reducing fall-related medical costs, with fees put at risk to substantiate this commitment. Additionally, their interventions have shown an increase in STAR ratings across HOS scores and have bolstered member retention. By implementing a proven methodology, Nymbl excels in identifying current and potential fall risk levels, alongside the associated costs of fall-related claims. The company intervenes proactively, often preventing a medically-diagnosed fall from occurring.

Nymbl Science, founded in 2014 and headquartered in the United States, operates within the Health Care, Health and Wellness, and Sports industries. Their most recent round of investment, a Corporate Round, took place on 21 February 2023, with Jogan Health stepping in as the investor. For further information on Nymbl’s offerings and how they can effectively mobilize members, interested parties can reach out to them via [email protected] or visit their website at nymblscience.com/for-health-plans.